Soolantra approved in Europe

Written by on March 28, 2015 in Soolantra (Ivermectin Cream 1%) with 2 Comments

Galderma has announced that Soolantra has been approve across the 28 European Member States. Soolantra was approved in the US by the FDA in December 2014, so the European approvals took just an additional 3 months.

Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA (ivermectin) Cream 10mg/g for Rosacea Patients

MARCH 27, 2015

– Novel treatment option for rosacea demonstrates efficacy in three Phase III studies –

Lausanne, Switzerland – 24 March 2015 – Galderma, a global specialty pharmaceutical company focused on dermatology, announced today a positive outcome of the European Decentralised Procedure (DCP) for SOOLANTRA (ivermectin) Cream 10mg/g for the once-daily topical treatment of inflammatory lesions of papulopustular rosacea in adult patients.

The Medical Products Agency (MPA) in Sweden acted as Reference Member State (RMS) on behalf of 28 EU Member States, which all agreed that SOOLANTRA Cream can be approved.

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed Connect on Pinterest Connect on Google Plus

2 Reader Comments

  1. Can’t wait till this is approved in New Zealand!

  2. Dave S says:

    When will it be available in pharmacies in Ireland ?

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.